- Home
- products
- asia middle east
- testing services targeting to preclinical studies
Show results for
Refine by
Testing Services Targeting To Preclinical Studies Equipment Supplied In Asia Middle East
29 equipment items found
Manufactured by:Elpiscience based inShanghai, CHINA
ES004 is a potentially best-in-class antibody targeting pan-allele signal-regulatory protein alpha (SIRPα). SIRPα is an inhibitory receptor expressed only on myeloid cells and dendritic cells. Binding of CD47 to SIRPα delivers a “don’t eat me” signal to suppress phagocytosis. Tumor cells frequently overexpress CD47 to evade macrophage-mediated destruction. To ...
Manufactured by:Elpiscience based inShanghai, CHINA
LAG3 is an immune checkpoint receptor known to suppress T cell activation. We designed ES005 to block LAG3 ligands, including MHC class II and FGL1. Through unique epitope binding, ES005 is able to recognize human LAG3 with high affinity. In preclinical studies, ES005 inhibited tumor growth both as a monotherapy and in combination with a PD-1 ...
Manufactured by:BRIM Biotechnology, Inc. based inTaipei City, TAIWAN
BRM423 is targeted to treat severe corneal damage. BRM423 is novel synthetic peptide derived from human Pigment Epithelium-Derived Factor (PEDF). Its active ingredient is the same as the BRM421 for Dry Eye Syndrome, but it is targeted to treat severe corneal damage. Based on BRIM’s proprietary PDSP technology platform, BRIM intends to rapidly advance development of this novel treatment for ...
by:OSSIO Inc based inWoburn, MASSACHUSETTS (USA)
OSSIOfiber® Cannulated and Solid-Core Fixation Nails allow surgeons to offer patients a strong and biointegrative solution for a wide range of surgical techniques. Comprised of OSSIOfiber® Intelligent Bone Regeneration Technology, Fully integrates into native anatomy without adverse inflammation,, as proven in pre-clinical studies, Rivals performance of metal headless cannulated ...
Manufactured by:Ito Co., Ltd. based inKawaguchi City, Saitama, JAPAN
High-end Combination Unit with 3 Independent Channels and Body Diagram ...
Manufactured by:Ito Co., Ltd. based inKawaguchi City, Saitama, JAPAN
High-end Combination Unit with 5 Independent Channels and Body Diagram ...
Distributed by:American Laboratory Products Company (ALPCO) based inSalem, INDIA
We offer a range of research tools required to identify novel Cardiovascular Disease and Oxidative Health biomarkers, enabling scientists to test their relevance in basic, preclinical and clinical studies. Cardiovascular Disease (CVD) encompasses a constellation of diseases related to the heart and/or circulatory system. Two primary risk factors for CVD include obesity and Type 2 Diabetes, both ...
Manufactured by:Algatech based inD.N Hevel Eilot, ISRAEL
The human eye is a highly complex organ comprised of multiple tissue types, layers, and components that must work perfectly in sync and be constantly maintained. The retina of the eye is especially vulnerable to oxidative damage because it is one of the highest oxygen-consuming tissues of the body and experiences some of the greatest production of ROS. Antioxidants, especially carotenoids, are a ...
Manufactured by:BRIM Biotechnology, Inc. based inTaipei City, TAIWAN
Neurotrophic Keratitis is a rare, degenerative disease characterised by corneal sensitivity reduction, spontaneous epithelium breakdown, and impairment of corneal healing. Currently, there is only one drug, Oxervate (Cenegermin), approved by the US FDA and EMA in 2018. Eye health is crucial to quality of life and BRIM is advancing new therapeutics to support patients affected by Neurotrophic ...
Manufactured by:Mesoblast Ltd. based inMelbourne, AUSTRALIA
MPC-25-IC is Mesoblast’s Phase 2 product candidate for the treatment of acute myocardial infarction. This is the first clinical study to evaluate an allogeneic cellular therapy delivered by intracoronary infusion in patients who have suffered an acute myocardial ...
Manufactured by:BiomX based inNess Ziona, ISRAEL
We are developing BX005, a topical phage cocktail that targets Staphylococcus aureus (S. aureus), a bacteria associated with the manifestation of the disease. This program leverages know-how and capabilities acquired under our previous programs with regard to topical formulation and clinical testing. In preclinical in vitro studies, BX005 was shown to be active against over 90% of strains of S. ...
Manufactured by:BiomX based inNess Ziona, ISRAEL
We are developing BX004, a phage therapy for CF patients with chronic Pseudomonas aeruginosa (P. aeruginosa) respiratory infections, a main contributor to morbidity and mortality in this disease. Phase 1b/2a clinical study in CF patients is composed of two parts. Results from Part 1 aimed to evaluate the safety, pharmacokinetics, and microbiologic/clinical activity are expected in Q3 of 2022. ...
Manufactured by:Pluristem Therapeutics Inc. based inHaifa, ISRAEL
PLX-Immune are cells that have been induced with tumor necrosis factor alpha (TNF-a) and interferon-gamma (IFN-g), to transiently alter their secretion profile. The product has been evaluated in pre-clinical studies and a peer-reviewed article in the journal Scientific Reports, from Nature, was published which examined the effect of the cells in over 50 lines of human cancerous cells. The results ...
by:OSSIO Inc based inWoburn, MASSACHUSETTS (USA)
Bio-Integrative OSSIOfiber® Hammertoe Fixation System. Innovation and Convenience Delivered In One Package. The combination of the implant plus disposable instrumentation provides easy insertion and secure fixation for proximal interphalangeal (PIP) fusion procedures while utilizing existing surgical ...
Manufactured by:Elpiscience based inShanghai, CHINA
ES002’s dual ATP-adenosine mechanism is a potentially powerful TME regulator and transformative cancer immunotherapy. In preclinical studies ES002 demonstrated significant single agent anti-tumor activity as well as an excellent tolerability profile. ES002 has also shown superior enzymatic inhibition and binding ...
Manufactured by:Pacific Edge Ltd based inDunedin,, NEW ZEALAND
Cxcolorectal is a prognostic gene signature for patients diagnosed with stage II or stage III colorectal cancer. The test predicts the aggressiveness of the tumour, allowing physicians to make the best decision regarding treatment for the ...
Manufactured by:Pluristem Therapeutics Inc. based inHaifa, ISRAEL
PLX-R18 cells release a combination of therapeutic proteins in response to a damaged or poorly functioning hematopoietic system; this system creates the blood cells that protect us from infection, uncontrolled bleeding and anemia. PLX-R18 is currently in a Phase I clinical trial to treat incomplete hematopoietic recovery following Hematopoietic Cell Transplantation (HCT) and in development to ...
Manufactured by:Elpiscience based inShanghai, CHINA
ES009: A Potential Best-in-Class Antibody Targeting LILRB2. ES009 is a potential best-in-class monoclonal antibody targeting LILRB2 designed to reprogram inhibitory myeloid cells to create an immune favorable TME. LILRB2 is an inhibitory receptor that suppresses myeloid cell activation. Blocking LILRB2 reverses immunosuppression by reprograming tumor-associated macrophages (TAMs) from M2 ...
Manufactured by:GS International Trade Co.,Ltd based in, CHINA
Property: Value/Description. Molecular Formula: C22H30N6O4S . Molecular Weight: 474.58 g/mol . Appearance: White to off-white crystalline powder. Melting Point: 187–189 °C. Boiling Point: 672.4 °C at 760 mmHg. Density: 1.4 ± 0.1 g/cm³. Solubility: - Slightly soluble in water - Soluble in DMSO, methanol; poorly soluble in ethanol. LogP (Partition Coeff.): ...
Manufactured by:Bruker Corporation based inBillerica, MASSACHUSETTS (USA)
Designed for the emerging market of preclinical and molecular MR imaging: The BioSpec series is designed for the emerging market of preclinical and molecular MR imaging. State-of-the-art MRI CryoProbe technology together with ultra high field USR magnets deliver high spatial resolution in vivo enabling customers to come closer to the molecular and cellular level research they desire. Thanks to ...